FDA records indicate that there are no current recalls for this drug.
Lingerie De Peau Invisible Skin-fusion Foundation With Sunscreen Broad Spectrum Spf 20 03 Beige Naturel
Are you a medical professional?
Trending Topics
Lingerie De Peau Invisible Skin-fusion Foundation With Sunscreen Broad Spectrum Spf 20 03 Beige Naturel Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
- For external use only.
on damaged or broken skin.
keep out of eyes. Rinse with water to remove.
if rash occurs.
If swallowed, get medical help or contact a Poison Control Center right away.
on damaged or broken skin.
if rash occurs.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
- Helps prevent sunburn
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Lingerie De Peau Invisible Skin-fusion Foundation With Sunscreen Broad Spectrum Spf 20 03 Beige Naturel Manufacturers
- Guerlain
Lingerie De Peau Invisible Skin-fusion Foundation With Sunscreen Broad Spectrum Spf 20 03 Beige Naturel | Guerlain
Shake well before use
For sunscreen use:
Apply liberally 15 minutes before sun exposure. Reapply at least every two hours. Use a water resistant sunscreen if swimming or sweating. Sun protection measures. Spending time in the sun increases your risk of skin cancer and early early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: Limit time in the sun, especially from 10 a.m. - 2 p.m. Wear long-sleeved shirts, pants, hats and sunglasses Children under 6 months: Ask a doctor. - Guerlain S.a
Lingerie De Peau Invisible Skin-fusion Foundation With Sunscreen Broad Spectrum Spf 20 03 Beige Naturel | Ranbaxy Pharmaceuticals Inc.
Levocetirizine dihydrochloride is available as 5 mg breakable (scored) tablets, allowing for the administration of 2.5 mg, if needed. Levocetirizine dihydrochloride tablets can be taken without regard to food consumption.
2.1 Adults and Children 12 Years of Age and OlderThe recommended dose of levocetirizine dihydrochloride tablets is 5 mg (1 tablet) once daily in the evening. Some patients may be adequately controlled by 2.5 mg (1/2 tablet) once daily in the evening.
2.2 Children 6 to 11 Years of AgeThe recommended dose of levocetirizine dihydrochloride tablets is 2.5 mg (1/2 tablet) once daily in the evening. The 2.5 mg dose should not be exceeded because the systemic exposure with 5 mg is approximately twice that of adults [see Clinical Pharmacology (12.3)].
2.4 Dose Adjustment for Renal and Hepatic ImpairmentIn adults and children 12 years of age and older with:
• Mild renal impairment (creatinine clearance [CL CR] = 50 to 80 mL/min): a dose of 2.5 mg once daily is recommended; • Moderate renal impairment (CL CR = 30 to 50 mL/min): a dose of 2.5 mg once every other day is recommended; • Severe renal impairment (CL CR = 10 to 30 mL/min): a dose of 2.5 mg twice weekly (administered once every 3 to 4 days) is recommended; • End-stage renal disease patients (CL CR < 10 mL/min) and patients undergoing hemodialysis should not receive levocetirizine dihydrochloride tablets.No dose adjustment is needed in patients with solely hepatic impairment. In patients with both hepatic impairment and renal impairment, adjustment of the dose is recommended.
Login To Your Free Account